In contrast, no association with survival was observed in our DLBCL cohort, while the AG/AA genotype of IFNB1 rs1051922, under the dominant model, was associated with a higher likelihood of achieving CR following chemotherapy, suggesting a potential role of this variant in treatment response rather than long-term survival. This evidence concerns the gene IFNB1 and diffuse large B-cell lymphoma.